Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | MRNA | TMO |
|---|
| Close | 145.62 | 648.43 |
| Market Cap | $58.1B | $240B |
| 1M | +125.91% | +10.75% |
| P/E (TTM) | — | 34.4 |
| Forward P/E | — | 21.8 |
| P/E 5-Yr Percentile | — | 65 |
| P/S | 25.8 | 5.2 |
| P/B | 8.5 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $145M | $12.0B |
| Revenue YoY | +2.1% | +10.5% |
| Gross Margin | 35.9% | — |
| Latest Quarter EPS | -1.97 | 4.68 |
| Avg Post-Earnings Move | ±4.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.36% |
| 90-Day Net Insider Buying | −$49.2M | −$38.9M |
MRNA · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
